AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Niemela, M Maenpaa, H Salven, P Summanen, P Poussa, K Laatikainen, L Jaaskelainen, J Joensuu, H
Citation: M. Niemela et al., Interferon alpha-2a therapy in 18 hemangioblastomas, CLIN CANC R, 7(3), 2001, pp. 510-516

Authors: Salven, P Anttonen, K Repo, H Joensuu, H Orpana, A
Citation: P. Salven et al., Endotoxins induce and interferon alpha suppresses vascular endothelial growth factor (VEGF) production in human peripheral blood mononuclear cells, FASEB J, 15(7), 2001, pp. 1318-1320

Authors: Salven, P Orpana, A Teerenhovi, L Joensuu, H
Citation: P. Salven et al., Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients, BLOOD, 96(12), 2000, pp. 3712-3718

Authors: Bondestam, J Salven, P Jaaskela-Saari, H Ikonen, T Lepantalo, M Mattila, S Joensuu, H
Citation: J. Bondestam et al., Major surgery increases serum levels of vascular endothelial growth factoronly temporarily, AM J SURG, 179(1), 2000, pp. 57-59

Authors: Salven, P Orpana, A Joensuu, H
Citation: P. Salven et al., Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor, CLIN CANC R, 5(3), 1999, pp. 487-491

Authors: Salven, P
Citation: P. Salven, Correspondence re: P. Salven et al., leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin. cancer res., 5 : 487-491, 1999. Reply, CLIN CANC R, 5(10), 1999, pp. 2979-2979

Authors: Salven, P Perhoniemi, V Tykka, H Maenpaa, H Joensuu, H
Citation: P. Salven et al., Serum VEGF levels in women with a benign breast tumor or breast cancer, BREAST CANC, 53(2), 1999, pp. 161-166

Authors: Ojala, PM Tiainen, M Salven, P Veikkola, T Castanos-Velez, E Sarid, R Biberfeld, P Makela, TP
Citation: Pm. Ojala et al., Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6, CANCER RES, 59(19), 1999, pp. 4984-4989

Authors: Vermeulen, PB Salven, P Benoy, I Gasparini, G Dirix, LY
Citation: Pb. Vermeulen et al., Blood platelets and serum VEGF in cancer patients, BR J CANC, 79(2), 1999, pp. 370-371

Authors: Salven, P Teerenhovi, L Joensuu, H
Citation: P. Salven et al., A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma, BLOOD, 94(10), 1999, pp. 3334-3339

Authors: Valtola, R Salven, P Heikkila, P Taipale, J Joensuu, H Rehn, M Pihlajaniemi, T Weich, H deWaal, R Alitalo, K
Citation: R. Valtola et al., VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer, AM J PATH, 154(5), 1999, pp. 1381-1390
Risultati: 1-11 |